Home
World Journal of Biology Pharmacy and Health Sciences
ISSN Approved | International, Peer reviewed, Referred, Open access Journal

Main navigation

  • Home
    • Journal Information
    • Abstracting and Indexing
    • Editorial Board Members
    • Reviewer Panel
    • Journal Policies
    • WJBPHS CrossMark Policy
    • Publication Ethics
    • Current Issue
    • Issue in Progress
    • Past Issues
    • Instructions for Authors
    • Article processing fee
    • Track Manuscript Status
    • Get Publication Certificate
    • Become a Reviewer panel member
    • Join as Editorial Board Member
  • Contact us
  • Downloads

ISSN Approved Journal | | IMPACT FACTOR 8.16 | | eISSN: 2582-5542 | |  Free Crossref DOI 

Fast Publication within 2 days | | Low Article Processing Charges | | Peer Reviewed and Referred Journal

Research and review articles are invited for publication in September 2026 (Volume 27, Issue 3) Submit Paper

Mammogram density estimation as breast cancer risk in intermediate-risk women in Warith International Cancer Institution

Breadcrumb

  • Home
  • Mammogram density estimation as breast cancer risk in intermediate-risk women in Warith International Cancer Institution

Wasan Mahdi Al-Ghanimi 1, *, Noufel Sh. Al-Shadood 1 and Hiba D. Al-Ameri 2

1 Warith International Cancer Institute, Karbalaa, Iraq.
2 Al-Imamein Al-Kadhimaein Medical City, Baghdad, Iraq.

Research Article
 
World Journal of Biology Pharmacy and Health Sciences, 2024, 19(01), 259–267.
Article DOI: 10.30574/wjbphs.2024.19.1.0427
DOI url: https://doi.org/10.30574/wjbphs.2024.19.1.0427

Received on 08 June 2024; revised on 20 July 2024; accepted on 22 July 2024

Introduction: Breast cancer is the second most common malignant tumor worldwide and the leading cause of cancer death among women in developing regions, including the Middle East and North Africa. This study aims to evaluate Mammogram Density Estimation for Assessing Breast Cancer Risk in Intermediate-Risk Women at Warith International Cancer Institution.
Methods: The study included 261 women aged 40-78 who visited the Warith International Cancer Institution in Karbala, Iraq, between May 2023 and April 2024. Participants were divided into two groups based on mammographic breast density (MBD) according to the BI-RADS classification: non-dense (fatty and scattered fibroglandular) and dense (heterogeneously dense and dense) breasts. Demographic and clinical data were collected, and the association between breast density and various breast conditions was analyzed using logistic regression.
Results: For malignant cases, the odds ratio (OR) for invasive ductal carcinoma (IDC) was 1.04, suggesting no significant difference in the likelihood of IDC between dense and non-dense breasts. The OR for ductal carcinoma in situ (DCIS) was 1.60, indicating a slightly higher, but not statistically significant, likelihood of DCIS in dense breasts. The overall OR for malignant cases was 1.26, showing a trend towards a higher likelihood of malignancy in dense breasts, but it was not statistically significant.
For benign conditions, the OR for fibrocystic changes was 1.76, suggesting a higher likelihood in dense breasts, but the results were not statistically significant. Similarly, the ORs for fibroadenoma (1.27) and simple cysts (1.40) showed a slight increase in dense breasts but without statistical significance. Abscess and duct ectasia were less likely in dense breasts, but the results were not statistically significant.
Conclusion: The study findings suggest that some breast conditions may be more common in dense breasts, but the differences are not statistically significant in many cases. Further targeted research is needed to understand better the relationships between breast density and various breast pathologies.

Colorectal Cancer; Breast Cancer; Family History; Association

https://wjbphs.com/sites/default/files/fulltext_pdf/WJBPHS-2024-0427.pdf

Preview Article PDF

Wasan Mahdi Al-Ghanimi, Noufel Sh. Al-Shadood and Hiba D. Al-Ameri. Mammogram density estimation as breast cancer risk in intermediate-risk women in Warith International Cancer Institution. World Journal of Biology Pharmacy and Health Sciences, 2024, 19(01), 259–267. Article DOI: https://doi.org/10.30574/wjbphs.2024.19.1.0427

Get Certificates

Get Publication Certificate

Download LoA

Check Corssref DOI details

Issue details

Issue Cover Page

Editorial Board

Table of content


Copyright © Author(s). All rights reserved. This article is published under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, sharing, adaptation, distribution, and reproduction in any medium or format, as long as appropriate credit is given to the original author(s) and source, a link to the license is provided, and any changes made are indicated.


Copyright © 2026 World Journal of Biology Pharmacy and Health Sciences (WJBPHS) - All rights reserved

Developed & Designed by VS Infosolution